We maintain our GGM-derived PBV TP of RM0.63 (COE: 9.2%, TG: 2.0%, ROE: 6.0%) and UNDERPERFORM call. Post meeting, we are encouraged by the group’s strategies to bolster NIMs and build stickiness for its products, helmed by targeted marketing to T20s and SMEs. We await further developments from this space which may uplift the group’s presently low ROEs which were chiefly dragged by high funding cost.
We came away from a meeting with MBSB where it elaborated on key initiatives to drive the group forward (to achieve its 3-year ROE target of 8%) along with some near-term updates. Key takeaways are as follows:
Post updates, we make no changes to our FY23F/FY24F assumptions. While we find the abovementioned efforts encouraging for the group, we reckon time may be needed for a positive fruition to earnings. Notwithstanding that, building these features may include near-term development costs which could also be subject to implementation risks.
Maintain UNDERPERFORM and TP of RM0.63. Our TP is based on an unchanged GGM-derived PBV of 0.56x (COE: 9.2%, TG: 2.0%, ROE: 6.0%) against FY24F BVPS of RM1.13. While investors may be keeping close tabs on the integration of MIDF into the group’s operations, synergies may only be extracted in a longer term.
Additionally, the group may also require greater efforts to reoptimize its funding mix especially given its low CASA levels, which may make it less attractive than its peers. Not helping either is its lowest ROE positioning against peers.
Risks to our call include: (i) lower-than-expected margin squeeze, (ii) higher-than-expected loans growth, (iii) slower-thanexpected deterioration in asset quality, (iv) further gains in capital market activities, (v) favourable currency fluctuations, and (vi) changes to OPR.
Source: Kenanga Research - 15 Jan 2024
Chart | Stock Name | Last | Change | Volume |
---|
Created by kiasutrader | Nov 20, 2024
Created by kiasutrader | Nov 20, 2024